Cargando…

Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells

SIMPLE SUMMARY: While targeting programmed cell death (PDCD) 1 is a central treatment against melanoma, little is known about the related protein PDCD4. We defined differences in melanoma PDCD4 subcellular localization (either total cellular or nuclear-only) during oncogenesis, evaluated its presenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Thuy T., Rane, Chetan K., Zito, Christopher R., Weiss, Sarah A., Jessel, Shlomit, Lucca, Liliana, Lu, Benjamin Y., Oria, Victor O., Adeniran, Adebowale, Chiang, Veronica L., Omay, Sacit Bulent, Hafler, David A., Kluger, Harriet M., Jilaveanu, Lucia B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958624/ https://www.ncbi.nlm.nih.gov/pubmed/33801444 http://dx.doi.org/10.3390/cancers13051049

Ejemplares similares

19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA
por: Oria, Victor, et al.
Publicado: (2020)

Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma
por: Oria, Victor O., et al.
Publicado: (2022)

Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases
por: Weiss, Sarah A., et al.
Publicado: (2020)

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors
por: Shuch, Brian, et al.
Publicado: (2015)

Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens
por: Baine, Marina K., et al.
Publicado: (2015)

Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma
por: Tran, Thuy T., et al.
Publicado: (2023)

Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells
por: Lucca, Liliana E., et al.
Publicado: (2021)

The Role of Surgical Approaches in the Multi-Modal Management of Adult Craniopharyngiomas
por: Hong, Christopher S., et al.
Publicado: (2022)

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance
por: Schoenfeld, David A., et al.
Publicado: (2022)

Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy
por: Tran, Thuy T., et al.
Publicado: (2019)

26. GENETIC CHARACTERIZATION OF SELLAR METASTASIS FROM PRIMARY BRONCHIAL CARCINOID TUMOR OF NEUROENDOCRINE PATHOLOGY
por: Hong, Christopher, et al.
Publicado: (2020)

Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases
por: Lu, Benjamin Y, et al.
Publicado: (2021)

Minimally Invasive Resection of Giant Neurocysticercal Cyst
por: Trubin, Paul Albert, et al.
Publicado: (2022)

[(11)C]Methionine and [(11)C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis
por: Tran, Thuy T., et al.
Publicado: (2020)

Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors
por: Caulfield, Jasmine I, et al.
Publicado: (2023)

Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure
por: Qu, Rihao, et al.
Publicado: (2022)

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors
por: Aziz, Saadia A, et al.
Publicado: (2013)

Genomic Characterization of Radiation-Induced Intracranial Undifferentiated Pleomorphic Sarcoma
por: Hong, Christopher S., et al.
Publicado: (2021)

PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma
por: Hong, Christopher S., et al.
Publicado: (2022)

Vascularity of primary and metastatic renal cell carcinoma specimens
por: Aziz, Saadia A, et al.
Publicado: (2013)

Subdural empyema secondary to pansinusitis after coronavirus disease 2019 infection in an immunocompetent patient: illustrative case
por: Hong, Christopher S., et al.
Publicado: (2023)

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases
por: Schoenfeld, David A, et al.
Publicado: (2023)

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma
por: Giesen, Eva, et al.
Publicado: (2014)

Comprehensive Genomic Characterization of A Case of Granular Cell Tumor of the Posterior Pituitary Gland: A Case Report
por: Hong, Christopher S., et al.
Publicado: (2021)

SAT-475 PRL Secreting Macroadenoma and Development CSF Leak Secondary to Cabergoline Use
por: Ulrich, Jenna, et al.
Publicado: (2019)

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
por: Aziz, Saadia A, et al.
Publicado: (2014)

Genetic characterization of a case of sellar metastasis from bronchial carcinoid neuroendocrine tumor
por: Christopher S, . Hong, et al.
Publicado: (2020)

Sporadic adamantinomatous craniopharyngioma with double-hit somatic APC mutations
por: Hong, Christopher S, et al.
Publicado: (2021)

MEK targeting in N-RAS mutated metastatic melanoma
por: Thumar, Jaykumar, et al.
Publicado: (2014)

PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
por: Jilaveanu, L.B., et al.
Publicado: (2014)

B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors
por: Damsky, William, et al.
Publicado: (2019)

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma
por: Su, David, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function
por: Jessel, Shlomit, et al.
Publicado: (2022)

Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells
por: Zito, Christopher R., et al.
Publicado: (2012)

A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma
por: Schoenfeld, David, et al.
Publicado: (2023)

NEIM-11 DEUTERIUM METABOLIC IMAGING (DMI) DETECTS A LARGER WARBURG EFFECT IN HIGH-GRADE BRAIN TUMORS AND IN IDH WILD TYPE GLIOMAS
por: Kim, Lauren, et al.
Publicado: (2023)

Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis
por: Xiao, Juan, et al.
Publicado: (2015)

Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2022)

Case Report: Suprasellar Pituitary Adenoma Presenting With Temporal Lobe Seizures
por: Hong, Christopher S., et al.
Publicado: (2020)

ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis
por: Mann, Jacqueline E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ht2gvrkdaoel3qrjjmug15ls3a